Table 1

P2X7genotype distribution for the study subjects (N=16)
Glu496Ala NullAllele (151+1g>t) rs35933842 Val76Ala rs175 25809 Arg117Trp rs28360445 Gly150Arg rs283 60447 His155Tyr rs208294 Glu186Lys rs28360451 Leu191Pro rs28 360452 Null Allele (699C→T) n.a. Arg270Cys rs16950860 Arg307Gln rs28360457 Ala348Thr rs1718119 Thr357Ser rs2230911 Gln460Arg rs2230912 Ile568Asn rs1653624 No. of subjects
HOMO WT WT WT WT WT WT WT WT WT WT WT WT WT WT 2
HOMO HET WT WT WT WT WT WT WT WT WT WT WT WT WT 3
HOMO WT WT WT WT HET WT WT WT WT WT WT WT WT WT 2
HOMO WT WT WT HET WT WT WT WT WT WT WT WT WT WT 1
HOMO WT WT WT HET WT WT WT HET WT WT WT WT WT WT 1
WT WT WT WT WT WT WT WT WT WT WT WT WT WT WT 7

HOMO: Homozygous for the variant allele.

HET: Heterozygous.

WT: Wild-type.

Wesselius et al.

Wesselius et al. BMC Immunology 2012 13:64   doi:10.1186/1471-2172-13-64

Open Data